Clinical Trial Update: Open Label, Zonegran (Zonisamide) In Partial Onset Seizures [Phase 4]

View source ↗

Summary

Phase 4 open-label study of Zonegran (zonisamide) for partial onset seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Zonegran (zonisamide)

Snippet

Sponsor: Eisai Limited | Conditions: Epilepsy | Phase 4 | Status: COMPLETED